Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31332169.
- Also identified by DOI 10.1038/s41467-019-11152-6 and PMC identifier 6646332.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Severe respiratory syncytial virus (RSV) infection is a major cause of morbidity and mortality in infants <2 years-old. Here we describe that high-fiber diet protects mice from RSV infection. This effect was dependent on intestinal microbiota and production of acetate. Oral administration of acetate mediated interferon-β (IFN-β) response by increasing expression of interferon-stimulated genes in the lung. These effects were associated with reduction of viral load and pulmonary inflammation in RSV-infected mice. Type 1 IFN signaling via the IFN-1 receptor (IFNAR) was essential for acetate antiviral activity in pulmonary epithelial cell lines and for the acetate protective effect in RSV-infected mice. Activation of Gpr43 in pulmonary epithelial cells reduced virus-induced cytotoxicity and promoted antiviral effects through IFN-β response. The effect of acetate on RSV infection was abolished in Gpr43<sup>-</sup><sup>/</sup><sup>-</sup> mice. Our findings reveal antiviral effects of acetate involving IFN-β in lung epithelial cells and engagement of GPR43 and IFNAR.
Medical subject headings
- Acetates
- Interferon Type I
- Microbiota
- Receptors, G-Protein-Coupled
- Respiratory Syncytial Virus Infections